Clinical Trial Update: Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating PSMA-based PET imaging for high-risk prostate cancer, and the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING